Literature DB >> 20600733

Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.

Thomas Perrier1, Patrick Saulnier, Florian Fouchet, Nolwenn Lautram, Jean-Pierre Benoît.   

Abstract

Over the last decade, Lipid NanoCapsules (LNCs) have been intensively used as effective drug delivery systems; they are classically prepared using a phase-inversion method. Following formulation of the LNCs, the molecular insertion of commercially-available disteraoylphosphatidylethanolamine-peg amphiphiles is performed into the LNC shell, using a post-insertion method, more classically applied with liposomes. The subsequent LNC interfacial modifications are investigated by using size and electrokinetic measurements. More particularly, the length and the nature of the hydrophilic part of the post-inserted surfactant are modified. The results are discussed in order to improve our understanding of post-insertion mechanisms. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600733     DOI: 10.1016/j.ijpharm.2010.06.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

Authors:  Serena Deiana; Akihito Watanabe; Yuki Yamasaki; Naoki Amada; Marlene Arthur; Shona Fleming; Hilary Woodcock; Patricia Dorward; Barbara Pigliacampo; Steve Close; Bettina Platt; Gernot Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-07-28       Impact factor: 4.530

2.  Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment.

Authors:  Yining Xu; Herlinde De Keersmaecker; Kevin Braeckmans; Stefaan De Smedt; Patrice D Cani; Véronique Préat; Ana Beloqui
Journal:  Biomaterials       Date:  2020-06-17       Impact factor: 12.479

3.  Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.

Authors:  Anne-Claire Groo; Kristina Mircheva; Jérôme Bejaud; Caroline Ailhas; Ivan Panaiotov; Patrick Saulnier; Tzvetanka Ivanova; Frederic Lagarce
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

4.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

5.  Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon.

Authors:  Yuqing Su; Mengyang Liu; Yan Xiong; Junqiang Ding; Xinrong Liu; Yanzhi Song; Yihui Deng
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

6.  Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.

Authors:  Rudolf Glueckert; Christian O Pritz; Soumen Roy; Jozsef Dudas; Anneliese Schrott-Fischer
Journal:  Front Aging Neurosci       Date:  2015-05-19       Impact factor: 5.750

7.  Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro.

Authors:  Catherine Fressinaud; Olivier Thomas; Anita Monika Umerska; Patrick Saulnier
Journal:  Neurochem Res       Date:  2020-09-10       Impact factor: 3.996

Review 8.  Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.

Authors:  Pierre Idlas; Elise Lepeltier; Gérard Jaouen; Catherine Passirani
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

9.  Tumor Microenvironment-Responsive Shell/Core Composite Nanoparticles for Enhanced Stability and Antitumor Efficiency Based on a pH-Triggered Charge-Reversal Mechanism.

Authors:  Qiuhua Luo; Wen Shi; Puxiu Wang; Yu Zhang; Jia Meng; Ling Zhang
Journal:  Pharmaceutics       Date:  2021-06-16       Impact factor: 6.321

10.  Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.

Authors:  Maha M Eissa; Riham M El-Moslemany; Alyaa A Ramadan; Eglal I Amer; Mervat Z El-Azzouni; Labiba K El-Khordagui
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.